Evaluating oliceridine as a treatment option for moderate to severe acute post-operative pain in adults

References

• Apfelbaum JL, Chen C, Mehta SS, et al. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003 Aug;972:534–540. table of contents.
   PubMed Web of Science ®Google Scholar
• Shahid Shafi M, Collinsworth AW, Copeland LA. MBA, MPH. association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system. JAMA Surg. 2018;153(8):757–763.
   PubMed Web of Science ®Google Scholar
• Weiser TG, Haynes AB, Molina G, et al. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016 Mar 1;94(3):201–209F.
   PubMed Web of Science ®Google Scholar
• Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287–2298.
   PubMed Web of Science ®Google Scholar
• Soffin EM, Lee BH, Kumar KK, et al. The prescription opioid crisis: role of the anaesthesiologist in reducing opioid use and misuse. Br J Anaesth. 2019 Jun;122(6):e198–e208.
   PubMed Web of Science ®Google Scholar
• Marcantonio ER, Goldman L, Mangione CM, et al. A clinical prediction rule for delirium after elective noncardiac surgery. JAMA. 1994 Jan;271(2):134–139.
   PubMed Web of Science ®Google Scholar
• Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618–1625.
   PubMed Web of Science ®Google Scholar
• Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007 Mar;41(3):400–407.
   PubMed Web of Science ®Google Scholar
• Higgins C, KM B. Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and metaanalysis. British Journal of Anaesthesia. 2018.
   Google Scholar
• Schuchat A, Houry D, Guy GP Jr. New data on opioid use and prescribing in the United States. JAMA. 2017 Aug 1;318(5):425–426.
   PubMed Web of Science ®Google Scholar
• Wardhan R, Chelly J. Recent advances in acute pain management: understanding the mechanisms of acute pain, the prescription of opioids, and the role of multimodal pain therapy. F1000Res. 2017;6:2065.
   PubMedGoogle Scholar
• Lam K, Soneji N, Katzberg H, et al. Incidence and etiology of postoperative neurological symptoms after peripheral nerve block: a retrospective cohort study. Reg Anesth Pain Med. 2020 [2020 Jul];45(7):495–504.
   PubMed Web of Science ®Google Scholar
• Rubin D, Matsumoto M, Weinberg G, et al. Local anesthetic systemic toxicity in total joint arthroplasty: incidence and risk factors in the united states from the national inpatient sample 1998-2013. Reg Anesth Pain Med. 2018;43(2):131-137.
   Web of Science ®Google Scholar
• Jeng CL, Torrillo TM, Rosenblatt MA. Complications of peripheral nerve blocks. Br J Anaesth. 2010 Dec;105(Suppl 1):i97–107.
   PubMedGoogle Scholar
• Costa A, Satalich J, Al-Bizri E, et al. A ten-year retrospective study of post-dural puncture headache in 32,655 obstetric patients. Can J Anaesth. 2019 Dec;
   Google Scholar
• Stephens J, Laskin B, Pashos C, et al. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors. Rheumatology (Oxford). 2003 Nov;42(Suppl 3):iii40–52.
   PubMedGoogle Scholar
• Carter JA, Black LK, Sharma D, et al. Efficacy of non-opioid analgesics to control postoperative pain: a network meta-analysis. BMC Anesthesiol. 2020 Oct 27;20(1):272.
   PubMed Web of Science ®Google Scholar
• Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity–where do we go from here? Expert Opin Drug Saf. 2007 Jul;6(4):341–355.
   PubMed Web of Science ®Google Scholar
• FDA. FDA requires new warnings for gabapentinoids about risk of respiratory depression | FDA. 2019.
   Google Scholar
• CL W, AB K, TM G, et al. American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative opioid minimization in opioid-naïve patients. Anesth Analg. 2019 Aug;129(2):567–577.
   PubMed Web of Science ®Google Scholar
• Frauenknecht J, Kirkham KR, Jacot-Guillarmod A, et al. Analgesic impact of intra-operative opioids vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anaesthesia. 2019 May;74(5):651–662.
   PubMed Web of Science ®Google Scholar
• CL W, AB K, TM G, et al. American society for enhanced recovery and perioperative quality initiative joint consensus statement on perioperative opioid minimization in opioid-naïve patients. Anesthesia Analg. 2019;129(2):567–577.
   PubMed Web of Science ®Google Scholar
• Dewinter G, Coppens S, Van de Velde M, et al. Quadratus lumborum block versus perioperative intravenous lidocaine for postoperative pain control in patients undergoing laparoscopic colorectal surgery: a prospective, randomized, double-blind controlled clinical trial. Ann Surg. 2018 Nov;268(5):769–775.
   PubMed Web of Science ®Google Scholar
• Gan TJ, Epstein RS, Leone-Perkins ML, et al. Practice patterns and treatment challenges in acute postoperative pain management: a survey of practicing physicians. Pain Ther. 2018 Dec;7(2):205–216.
   PubMed Web of Science ®Google Scholar
• Ramsin Benyamin M, Trescot AM, et al. opioid complications and side effects. Pain Physician. 2008;11:S105–S120.
   PubMed Web of Science ®Google Scholar
• Viscusi ER. Improving the therapeutic window of conventional opioids: novel differential signaling modulators. Reg Anesth Pain Med. 2019 Jan;44(1):32–37.
   PubMed Web of Science ®Google Scholar
• Izrailtyan I, Qiu J, Overdyk FJ, et al. Risk factors for cardiopulmonary and respiratory arrest in medical and surgical hospital patients on opioid analgesics and sedatives. PLoS One. 2018;13(3):e0194553.
   PubMed Web of Science ®Google Scholar
• Overdyk FJ, Dowling O, Marino J, et al. Association of opioids and sedatives with increased risk of in-hospital cardiopulmonary arrest from an administrative database. PLoS One. 2016;11(2):e0150214.
   PubMed Web of Science ®Google Scholar
• Sun EC, Darnall BD, Baker LC, et al. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016 09; 176(9): 1286–1293.
   PubMed Web of Science ®Google Scholar
• Parra-Sanchez I, Abdallah R, You J, et al. A time-motion economic analysis of postoperative nausea and vomiting in ambulatory surgery. Can J Anaesth. 2012 Apr;59(4):366–375.
   PubMed Web of Science ®Google Scholar
• Wittbrodt ET, Gan TJ, Datto C, et al. Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery. J Pain Res. 2018;11:1017–1025.
   PubMed Web of Science ®Google Scholar
• Ho HS. Patient-controlled analgesia versus oral controlled-release oxycodone - are they interchangeable for acute postoperative pain after laparoscopic colorectal surgeries? Oncology. 2008;74(Suppl 1):61–65.
   PubMedGoogle Scholar
• Hong D, Flood P, Diaz G. The side effects of morphine and hydromorphone patient-controlled analgesia. Anesth Analg. 2008 Oct;107(4):1384–1389.
   PubMed Web of Science ®Google Scholar
• Felden L, Walter C, Harder S, et al. Comparative clinical effects of hydromorphone and morphine: a meta-analysis. Br J Anaesth. 2011 Sep;107(3):319–328.
   PubMed Web of Science ®Google Scholar
• Wang H, Friedman E, Olmstead M, et al. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Neuroscience. 2005;135(1):2005.
   Web of Science ®Google Scholar
• Traynor J. μ-Opioid receptors and regulators of G protein signaling (RGS) proteins: from a symposium on new concepts in mu-opioid pharmacology.Drug Alcohol Depend. 2012 [2012 Jan 03];121(3):173–180.
   PubMed Web of Science ®Google Scholar
• Cahill T, Thomsen A, Tarrasch J, et al. Distinct conformations of GPCR-β-arrestin complexes mediate desensitization, signaling, and endocytosis. Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2562–2567.
   Google Scholar
• DeWire S, Ahn S, Lefkowitz R, et al. Beta-arrestins and cell signaling. Annu Rev Physiol. 2007;69:483-510.
   Web of Science ®Google Scholar
• Georgoussi Z, Leontiadis L, Mazarakou G, et al. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling. Cell Signal. 2006 [2006 Jun];18(6):771–782.
   PubMed Web of Science ®Google Scholar
• Zuo Z. The role of opioid receptor internalization and ?beta-arrestins in the development of opioid tolerance.Anesth Analg. 2005 [2005Sep];101(3):3.
   Web of Science ®Google Scholar
• DeWire S, Yamashita D, Rominger D, et al. A G protein-biased ligand at the μ opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J Pharmacol Exp Ther. 2013 [2013 Mar];344(3):708–717.
   PubMed Web of Science ®Google Scholar
• Fda. FDA Approves New Opioid for Intravenous Use in Hospitals, Other Controlled Clinical Settings 2020 [updated Fri, 08/ 07/2020-19:00;cited 2020 Nov 29]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-opioid-intravenous-use-hospitals-other-controlled-clinical-settings
   Google Scholar
• Fossler M, Sadler B, Farrell C, et al. Oliceridine (TRV130), a novel G protein-biased ligand at the μ-opioid receptor, demonstrates a predictable relationship between plasma concentrations and pain relief. i: development of a pharmacokinetic/pharmacodynamic model. J Clin Pharmacol. 2018;58(6):750–761.
   Web of Science ®Google Scholar
• Fossler M, Sadler B, Farrell C, et al. Oliceridine, a novel G protein-biased ligand at the μ-opioid receptor, demonstrates a predictable relationship between plasma concentrations and pain relief. ii: simulation of potential phase 3 study designs using a pharmacokinetic/pharmacodynamic model. J Clin Pharmacol. 2018;58(6):762–770.
   Web of Science ®Google Scholar
• Nafziger A, Arscott K, Cochrane K, et al. The influence of renal or hepatic impairment on the pharmacokinetics, safety, and tolerability of oliceridine. Clinical pharmacology in drug development. 2020 Jul;9(5):639–650.
   Google Scholar
• Viscusi E, Webster L, Kuss M, et al. A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain. Pain. 2016 2016 Jan;157(1). ( Clinical trial of Oliceridine IV bolus in bunionectomy) 264–272
   PubMed Web of Science ®Google Scholar
• Singla N, Minkowitz H, Soergel D, et al. A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty. J Pain Res. 2017 10/ 06/2017;10.(Clinical trial of Oliceridine PCA in abdominoplasty);Volume 10:2413–2424.
   Web of Science ®Google Scholar
• Viscusi E, Skobieranda F, Soergel D, et al. APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy. J Pain Res. 2019 2019 Nov 03;12. ( Clinical trial of Oliceridine PCA in bunionectomy) https://doi.org/10.2147/JPR.S171013
   Google Scholar
• Singla N, Skobieranda F, Soergel D, et al. APOLLO-2: a randomized, placebo and active-controlled phase iii study investigating oliceridine (TRV130), a G protein-biased ligand at the μ-opioid receptor, for management of moderate to severe acute pain following abdominoplasty. pain practice : the official journal of world institute of pain. Clinical trial of Oliceridine PCA in abdominoplasty. 2019 2019Sep; 197
   Google Scholar
• Schraag S, Pradelli L, Alsaleh A, et al. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol. 2018 [2018 Aug 11];18(1). https://doi.org/10.1186/s12871-018-0632-3.
   Google Scholar
• Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004 Jun 10;350(24):2441–2451.
   PubMed Web of Science ®Google Scholar
• Dahan A, van Dam C, Niesters M, et al. Benefit and risk evaluation of biased μ-receptor agonist oliceridine versus morphine. Anesthesiology. 2020 [2020 Sep];133(3):3.
   Web of Science ®Google Scholar
• Ayad S, Demitrack M, Burt D, et al. Evaluating the incidence of opioid-induced respiratory depression associated with oliceridine and morphine as measured by the frequency and average cumulative duration of dosing interruption in patients treated for acute postoperative pain. Clin Drug Investig. 2020 [2020 Aug];40(8):755–764.
   PubMed Web of Science ®Google Scholar
• Bergese SD, Brzezinski M, Hammer GB, et al. ATHENA: a Phase 3, open-label study of the safety and effectiveness of oliceridine (TRV130), A G-PROTEIN SELECTIVE AGONIST AT THE µ-OPIOID RECEPTOR, IN PATIENTS WITH MODERATE TO SEVERE ACUTE PAIN REQUIRING PARENTERAL OPIOID THERAPY. J Pain Res. 2019;12:3113–3126.
   PubMed Web of Science ®Google Scholar
• Cashman J, Dolin S. Respiratory and haemodynamic effects of acute postoperative pain management: evidence from published data.Br J Anaesth. 2004 [2004 Aug];93(2):2.
   Web of Science ®Google Scholar
• Bergese S, Berkowitz R, Rider P, et al. Low incidence of postoperative respiratory depression with oliceridine compared to morphine: a retrospective chart analysis. Pain Res Manag. 2020 10/ 24/2020;2020:1–10.
   PubMed Web of Science ®Google Scholar
• Bohn L, Lefkowitz R, Caron M Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2002 12;22(23).
   Google Scholar
• KM R, LM B. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology 2011;60(1):58-65.
   Web of Science ®Google Scholar
• Altarifi A, David B, Muchhala K, et al. Effects of acute and repeated treatment with the biased mu opioid receptor agonist TRV130 (oliceridine) on measures of antinociception, gastrointestinal function, and abuse liability in rodents. J Psychopharmacol. 2017 [2017Jun];31(6):730–739.
   PubMed Web of Science ®Google Scholar
• Liang D, Li W, Nwaneshiudu C, et al. Pharmacological characters of oliceridine, a μ-opioid receptor g-protein-biased ligand in mice. Anesth Analg. 2019 [2019 Nov];129(5):1414–1421.
   Web of Science ®Google Scholar
• Lee M, Silverman S, Hansen H, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011 [Mar-Apr 2011];14:2.
   Web of Science ®Google Scholar
• Aberoumandi S, Vousooghi N, Tabrizi B, et al. Heroin-based crack induces hyperalgesia through β-arrestin 2 redistribution and phosphorylation of Erk1/2 and JNK in the periaqueductal gray area. Neurosci Lett. 2019 04/17/2019;698:133–139.
   PubMed Web of Science ®Google Scholar
• Bohn L, Gainetdinov R, Lin F, et al. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature. 2000 [2000 Jul 12];408(6813):720–723.
   PubMed Web of Science ®Google Scholar
• Connor M, Bagley E, Chieng B, et al. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. Br J Pharmacol. 2015 [2015 Jan];172(2):492–500.
   Web of Science ®Google Scholar